Royal Bank Of Canada Xortx Therapeutics Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.54 - $0.8 $232 - $344	430 Added 355.37%	551 $0
Q2 2023 Aug 14, 2023	BUY	$0.45 - $0.81 $14 - $26	33 Added 37.5%	121 $0
Q1 2023 May 15, 2023	SELL	$0.45 - $0.87 $158 - $306	-352 Reduced 80.0%	88 $0
Q4 2022 Feb 14, 2023	BUY	$0.73 - $10.71 $264 - $3,887	363 Added 471.43%	440 $0
Q3 2022 Nov 14, 2022	SELL	$0.94 - $10.98 $787 - $9,201	-838 Reduced 91.58%	77 $0
Q2 2022 Aug 15, 2022	SELL	$1.16 - $1.97 $903 - $1,534	-779 Reduced 45.99%	915 $1,000
Q1 2022 May 16, 2022	BUY	$1.16 - $2.15 $1,324 - $2,455	1,142 Added 206.88%	1,694 $3,000
Q4 2021 Feb 14, 2022	BUY	$1.8 - $5.84 $993 - $3,223	552 New	552 $1,000

Ticker XRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,389,700
Market Cap $17.1M
Description
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic ki...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.